Bakker C M, Blankensteijn J D, Schlejen P, Porte R J, Gomes M J, Lampe H I, Stibbe J, Terpstra O T
Department of Internal Medicine, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.
HPB Surg. 1994;7(4):265-80. doi: 10.1155/1994/27915.
We compared hemostatic changes during OLT and HLT after various periods of graft storage, to investigate whether the host liver in HLT protects the recipient from hemostatic deterioration induced by severe graft storage damage. In particular, the mechanism of fibrinolytic deterioration was investigated. The effect of prostaglandin E1 (PGE1) on these parameters was also studied.
69 pigs underwent either OLT (N = 32) or HLT (N = 37) with a graft stored for 2 hr (N = 31), 24 hr (N = 16), 48 hr (N = 7), or 72 hr (N = 15). PGE1 was given intravenously to both donor and recipient animals and was added to the preservation and flushing solutions. Fibrinolysis (euglobulin clot lysis time, t-PA activity and alpha 2-antiplasmin) and coagulation parameters (activated partial thromboplasmin time, prothrombin time, fibrinogen and platelet count) were measured at several intervals during transplantation.
Univariate non-parametric tests were used for analysis of coagulation and fibrinolysis parameters. For the three main variables- i.e., the type of transplantation, the use of PGE1, and the preservation time, multiple regression analysis was performed.
Fibrinolytic activity increased during the anhepatic period of OLT. Graft reperfusion was followed by a rise in t-PA in both OLT and HLT. In HLT, t-PA quickly returned to normal, whereas a continuous increase was found in OLT. The coagulation parameters, in turn, remained unchanged during the anhepatic period and deteriorated in OLT compared to HLT. The duration of graft storage was directly related to the severity of the hemostatic changes, although this effect was more apparent in OLT than in HLT.
Changes in hemostasis are more pronounced in OLT than in HLT. This suggests that the host liver protects the recipient from the effects of graft storage damage, even after long preservation times. Early postreperfusion fibrinolytic activity was presumably due to t-PA release from the graft both in OLT and HLT. The further rise t-PA in OLT might be caused by the release of cytokines from the graft, that subsequently evoke endothelial t-PA release. In HLT, t-PA and cytokines may be cleared by the native liver. No positive or negative effect of PGE1 on coagulation or fibrinolysis parameters was noticed.
我们比较了不同保存时间的移植物在原位肝移植(OLT)和同种异体肝移植(HLT)过程中的止血变化,以研究HLT中的宿主肝脏是否能保护受体免受严重移植物保存损伤引起的止血恶化。特别地,研究了纤溶恶化的机制。还研究了前列腺素E1(PGE1)对这些参数的影响。
69头猪接受OLT(n = 32)或HLT(n = 37),移植物保存2小时(n = 31)、24小时(n = 16)、48小时(n = 7)或72小时(n = 15)。将PGE1静脉注射给供体和受体动物,并添加到保存液和冲洗液中。在移植过程中的几个时间点测量纤溶(优球蛋白凝块溶解时间、组织型纤溶酶原激活物活性和α2 -抗纤溶酶)和凝血参数(活化部分凝血活酶时间、凝血酶原时间、纤维蛋白原和血小板计数)。
使用单变量非参数检验分析凝血和纤溶参数。对于三个主要变量,即移植类型、PGE1的使用和保存时间,进行了多元回归分析。
OLT无肝期纤溶活性增加。移植物再灌注后,OLT和HLT中的组织型纤溶酶原激活物均升高。在HLT中,组织型纤溶酶原激活物迅速恢复正常,而在OLT中则持续升高。相反,凝血参数在无肝期保持不变,与HLT相比,OLT中的凝血参数恶化。移植物保存时间与止血变化的严重程度直接相关,尽管这种影响在OLT中比在HLT中更明显。
OLT中的止血变化比HLT中更明显。这表明宿主肝脏即使在长时间保存后也能保护受体免受移植物保存损伤的影响。再灌注后早期的纤溶活性可能是由于OLT和HLT中移植物释放组织型纤溶酶原激活物。OLT中组织型纤溶酶原激活物的进一步升高可能是由于移植物释放细胞因子,随后引起内皮细胞释放组织型纤溶酶原激活物。在HLT中,组织型纤溶酶原激活物和细胞因子可能被天然肝脏清除。未观察到PGE1对凝血或纤溶参数有正面或负面影响。